Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.51 |
| ▸ | MMP2 | P08253 | 1/20 | 0.51 |
| ▸ | MMP9 | P14780 | 1/20 | 0.51 |
| ▸ | MMP12 | P39900 | 1/20 | 0.51 |
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
| ▸ | PAM | P19021 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 4/20 | 0.49 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | PPARD | Q03181 | 2/20 | 0.45 |
| ▸ | PPARA | Q07869 | 2/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1158016 | 1.00 | MMP1 (0.51) | MMP1MMP2MMP9MMP12IDO1 | |
| Thiophene SCHEMBL28361115 | 0.91 | CACNA1B (0.46) | MMP1MMP2MMP9MMP12IDO1 | |
| SCHEMBL293067 | 0.89 | IDO1 (0.57) | MMP1MMP2MMP9MMP12IDO1 | |
| SCHEMBL28456436 | 0.85 | GRIK1 (0.44) | MMP2MMP9NPC1CACNA1BRAB9A | |
| SCHEMBL3292040 | 0.85 | MEN1 (0.51) | MMP1MMP2MMP9MMP12IDO1 | |
| SCHEMBL3292037 | 0.85 | MEN1 (0.51) | MMP1MMP2MMP9MMP12IDO1 | |
| SCHEMBL28425115 | 0.84 | MMP1 (0.52) | MMP1MMP2MMP9MMP12IDO1 | |
| SCHEMBL3297767 | 0.83 | GSK3B (0.58) | RAB9AALDH1A1 | |
| SCHEMBL4842741 | 0.83 | NOS2 (0.49) | POLBMEN1KMT2A | |
| SCHEMBL3292230 | 0.83 | GSK3B (0.58) | RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11827781-B2 | Photosensitive resin composition and use thereof | ZHEJIANG FIRST ADVANCED MATERIAL R&D INSTITUTE CO., LTD. (CN) | 2023-11-28 | — | — | US | claimed |
| EP-4024133-A1 | PHOTOSENSITIVE RESIN COMPOSITION AND APPLICATION THEREOF | Zhejiang First Advanced Material R&D Institute Co., Ltd. (CN) | 2022-07-06 | — | — | EP | claimed |
| US-20220145072-A1 | PHOTOSENSITIVE RESIN COMPOSITION AND USE THEREOF | HANGZHOU FIRST ELECTONIC MATERIAL CO., LTD (CN) | 2022-05-12 | — | — | US | claimed |
| CN-110515271-B | Photosensitive resin composition and application thereof | 浙江福斯特新材料研究院有限公司 | 2022-03-11 | — | — | CN | claimed |
| CN-118852080-A | Chiral amino chromanone derivative and synthesis method thereof | 上海市奉贤区中心医院 | 2024-10-29 | — | — | CN | disclosed |
| CN-118852080-A | Chiral amino chromanone derivative and synthesis method thereof | 上海市奉贤区中心医院 | 2024-10-29 | — | — | CN | disclosed |
| CN-115108938-B | Chiral alpha-substituted deuterated amino acid compound and preparation method thereof | 武汉大学 | 2024-04-19 | — | — | CN | disclosed |
| CN-113912577-B | Rockwell intermediate, rockwell and its derivative, and preparation and application | 深圳湾实验室 | 2023-12-29 | — | — | CN | disclosed |
| CN-114105822-B | Pseudo C 2 Symmetrical chiral diallyl substituted compound and preparation method and application thereof | 武汉大学 | 2023-12-01 | — | — | CN | disclosed |
| US-11827781-B2 | Photosensitive resin composition and use thereof | ZHEJIANG FIRST ADVANCED MATERIAL R&D INSTITUTE CO., LTD. (CN) | 2023-11-28 | — | — | US | disclosed |
| CN-114736108-B | Allyl carbonyl enol compound and synthesis method thereof | 同济大学 | 2023-10-27 | — | — | CN | disclosed |
| CN-115108938-A | Chiral alpha-substituted deuterated amino acid compound and preparation method thereof | 武汉大学 | 2022-09-27 | — | — | CN | disclosed |
| US-6506908-B2 | From bicyclo(3.1.0)hexabe; decyclization; decarboxylation | MERCK & CO., INC. | 2003-01-14 | — | — | US | disclosed |
| US-20020198383-A1 | Catalytic compositions and methods for asymmetric allylic alkylation | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-12-26 | — | — | US | disclosed |
| US-20020016492-A1 | Process for preparing 3-hydroxymethyl-4-(aryl or heterocyclic)-cyclopentanones | MERCK SHARP & DOHME CORP. | 2002-02-07 | — | — | US | disclosed |
| US-20010034419-A1 | Radiation transparent molding materials | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2001-10-25 | — | — | US | disclosed |
| EP-1049537-A2 | CATALYTIC COMPOSITIONS AND METHODS FOR ASYMMETRIC ALLYLIC ALKYLATION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2000-11-08 | — | — | EP | disclosed |
| US-6130349-A | USING COMPLEX OF MOLYBDENUM, TUNGSTEN OR CHROMIUM WITH 1,1*-BINAPHTHYL SYSTEM CONTAINING HETEROCYCLIC NITROGEN GROUP; ENANTIO- AND REGIOSELECTIVITY | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2000-10-10 | — | — | US | disclosed |
| WO-1999032225-A9 | CATALYTIC COMPOSITION BASED ON CHIRAL LIGANDS WITH MOLYBDENUM, TUNGSTEN OR CHROMIUM AND METHOD FOR ASYMMETRIC ALKYLATION OF ALLYLIC SUBSTRATES | UNIV LELAND STANFORD JUNIOR (US) | 1999-09-30 | — | — | WO | disclosed |
| WO-1999032225-A2 | CATALYTIC COMPOSITION BASED ON CHIRAL LIGANDS WITH MOLYBDENUM, TUNGSTEN OR CHROMIUM AND METHOD FOR ASYMMETRIC ALKYLATION OF ALLYLIC SUBSTRATES | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 1999-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020198383-A1 | Catalytic compositions and methods for asymmetric allylic alkylation | MPG, UNG, APOBEC3C | MMP1 3740/4885MMP2 2616/4885MMP9 2696/4885 |
| US-20020016492-A1 | Process for preparing 3-hydroxymethyl-4-(aryl or heterocyclic)-cyclopentanones | CCR1, CCR5, CCR6 | MMP1 1856/4885MMP2 2843/4885MMP9 1665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.